more school than those with respiratory illnesses of other etiologies. 4, 5 Few studies have assessed the burden of school absenteeism due to laboratory-confirmed influenza, [5] [6] [7] and only one was conducted after the recommendation for annual influenza vaccination in children in the United States. 5 Absenteeism data on the relative contribution of ARIs caused by viruses other than influenza are lacking. Non-influenza viral illnesses may be less common, but also likely to disrupt usual activities and cause increased school absenteeism. Quantifying school absenteeism due to specific viruses can help target prevention or treatment strategies to reduce burden in school-aged children.
We utilized data from an observational influenza vaccine effectiveness study to evaluate parental-reported school absenteeism across three seasons among children with medically attended ARI due to various viruses. Specifically, we aim to estimate the average days absent for specific respiratory viruses in children, identify risk factors for prolonged (>2 days) absence from school due to viral ARIs, and evaluate the association between influenza vaccination and prolonged absence among children with influenza.
| METHODS
We conducted an analysis using follow-up surveys from children with were contacted for a follow-up interview. For children, interviews were conducted with a parent or guardian and included questions about when the child returned to normal activities, how many days the child missed school due to the illness (numerically open-ended), and medications prescribed and taken. The answer to the question, "how many days of school did your child miss, due to this illness" was used to assess school absenteeism. Responses larger than the maximum number of weekdays between illness onset and follow-up interviews were truncated to the maximum weekdays within the interval (nine observations were truncated). 
| Laboratory testing

| Statistical analysis
For this study, we included children 5-17 years old at the time of enrollment in the influenza VE study, whose parent or guardian had participated in the follow-up interview and who attended school outside the home.
Demographic and clinical characteristics were compared using χ 2 tests. Absenteeism rate was estimated by dividing the total number of days missed by the number of children with the infection. Negative binomial regression models were used to estimate the average days absent and 95% confidence interval (CI) for each viral infection category because absenteeism was skewed to the right. All variables potentially associated with days absent were added to the initial model. All analyses were performed using sAs statistical software (version 9.3; SAS Institute, Cary, NC, USA). Respondents and non-respondents were similar with regard to age, sex, race/ethnicity, reported symptoms, influenza vaccination status, and time from illness onset to influenza VE study enrollment (data not shown). Respondents were more likely to be enrolled in the influenza VE study during the period after influenza circulation peaked (63% vs 46%, P<.0001). Among respondents, 55 (5%) were excluded because they did not attend school outside the home (n=37), had influenza B with no lineage data (n=12), had influenza A and B or B/Yamagata and B/Victoria coinfection and could not be classified into a single influenza virus group (n=3), or had missing data on days absent from school (n=3).
| RESULTS
During
Among the 1027 children included in this study, viral infections were detected in 747 (73%) ( Table 1) The age distribution varied across viral categories. Coinfections and infections with metapneumovirus were more common in children 5-8 years old relative to older children, while having no viral infection detected and coronavirus was more common in children 9-17 years old. There were no differences in sex, race/ethnicity, or reported health status prior to infection between viral groups. Less than half (42%) of all subjects had received influenza vaccine prior to illness onset. Fever was more commonly reported among children with influenza infection than those with other viral infection or no viral infection detected. There was no difference in duration of illness or time from illness onset to completion of follow-up survey across viral categories; the majority (58%) of subjects completed their follow-up interviews within 7-10 days of illness onset.
| Mean days absent
In total, 2295 days of school were missed by our study population over three influenza seasons; 175 (17%) children did not miss any days. The 2012-2013 season, reported fair/poor health status prior to illness, enrollment during the peak influenza season, and receipt of antivirals were associated with greater mean days absent from school ( Table 2 ).
Longer duration of illness, being fatigued, having a fever, being short of breath, and having a sore throat were also associated with greater mean days absent. There were no differences in mean days absent by age group, sex, race/ethnicity, or influenza vaccination status. 
| Risk factors for prolonged absence
Most children (62%) missed two or fewer days of school due to their medically attended ARI. The 2012-2013 season and peak influenza season were associated with prolonged absence of >2 days (Table 2) .
Longer duration of illness, being fatigued, and having a fever were also associated with prolonged absence. There were no differences in prolonged absence by age group, sex, reported health status prior to illness, influenza vaccination status, or receipt of antivirals. 55 (59) 80 (98) 19 (25) 28 (33) 3 (8) 4 (14) 14 (19) 9 (20) 67 ( 23 (27) 26 (68) 3 (11) 26 (36) 16 (36) 100 (35) 2014-2015 0
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| DISCUSSION
In this study, we evaluated the association between specific viral infections and school absence. Influenza, RSV, coronaviruses, and rhinoviruses were the most commonly detected viruses in children 5-17 years old with medically attended acute respiratory illness, and viral illness accounted for about 75% of missed school days. Influenza contributed to a substantial burden on school absenteeism, averaging over one missed school day per illness and over 40% missing >2 days.
School absenteeism due to ARI caused by other viruses contributed to fewer days missed, but was common.
Influenza accounted for almost half of days absent by children with medically attended acute respiratory illness. Seasons predominated by A/H3N2 tend to be associated with increased morbidity and mortality, [19] [20] [21] but there was no difference in the average days missed due to influenza between children with different subtypes or lineage in our study population. However, children with influenza B/Yamagata infection were more likely to have prolonged absence than children with influenza A. The reason for this is unclear; influenza B infection rates are highest in school-aged children, and those with influenza B were more likely to seek medical attention, 1,22 but more cases of A/H3N2
were identified in our study. In contrast, previous studies have found lower, but similar absenteeism rates by influenza type 6, 7 and are consistent with studies indicting similar clinical features among children with influenza A and B.
7,23-25
Influenza vaccination did not impact school absenteeism among children with influenza in our study. Previous studies have found substantially lower absenteeism rates among vaccinated children compared to unvaccinated children, but these studies examined absenteeism due to non-specific respiratory illness rather than laboratory-confirmed influenza, and residual confounding may have occurred. 4, 26 School absenteeism rates were also lower in schools/ communities with school-based vaccination programs. 5, [27] [28] [29] [30] These studies did not assess the reason for absenteeism or were limited to influenza-like illness. It is possible that vaccination may have resulted in milder illness, leading to fewer outpatient visits. Our study population was restricted to respiratory illnesses that were severe enough to seek medical attention, and was not able to assess mild illness due to vaccination that may have resulted in fewer school days missed.
However, a prior randomized placebo-controlled trial in children with influenza B found no difference in duration of illness between those receiving the vaccine and those receiving a placebo. 31 For children under five years old, RSV causes significant morbidity, with hospitalization rates higher than those reported for influenza. [32] [33] [34] For older children and adults, RSV typically causes more mild illness than influenza. 13 In our study, the prevalence of RSV infection and school absenteeism due to RSV was lower than that among children with influenza, consistent with milder illness compared to influenza.
However, this contrasts a previous study among children attending the emergency room in Italy, where there was no difference in median days missed from school between children infected with RSV and influenza. 35 The median days missed were much higher (10-12 days) than those in our outpatient study, suggesting emergency room visits may have been more severe in general and may explain discrepancies between the two studies.
RSV, coronavirus, and rhinovirus were prevalent during all seasons examined, but these viruses contributed to fewer missed school days. This is not surprising as coronaviruses and rhinoviruses are the T A B L E 2 (Continued) most frequently identified viruses, but are less likely to be medically attended. 1 Although the prevalence of metapneumovirus was low, estimated mean days missed due to metapneumovirus was similar to RSV, consistent with a study that found similar school absenteeism rates among children with metapneumovirus and children with RSV. 35 While most children are infected with these viruses before the age of 5 years, reinfection is common and contributes to school absenteeism among school-aged children.
This study had several limitations. Data on school absenteeism due to RSV should be considered when estimating the direct and indirect impact of potential RSV vaccine policies.
